Aditya Shreenivas

781 total citations
47 papers, 340 citations indexed

About

Aditya Shreenivas is a scholar working on Oncology, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Aditya Shreenivas has authored 47 papers receiving a total of 340 indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Oncology, 17 papers in Surgery and 12 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Aditya Shreenivas's work include Pancreatic and Hepatic Oncology Research (9 papers), Cancer Genomics and Diagnostics (9 papers) and Colorectal Cancer Treatments and Studies (5 papers). Aditya Shreenivas is often cited by papers focused on Pancreatic and Hepatic Oncology Research (9 papers), Cancer Genomics and Diagnostics (9 papers) and Colorectal Cancer Treatments and Studies (5 papers). Aditya Shreenivas collaborates with scholars based in United States, India and United Kingdom. Aditya Shreenivas's co-authors include Sewanti Limaye, Jeffrey F. Krane, Robert I. Haddad, Jochen H. Lorch, Roy B. Tishler, Marshall R. Posner, Deborah Dillon, Ben George, Razelle Kurzrock and Shumei Kato and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Aditya Shreenivas

41 papers receiving 334 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Aditya Shreenivas United States 9 220 194 67 65 43 47 340
Dan Ma China 8 188 0.9× 208 1.1× 102 1.5× 36 0.6× 23 0.5× 23 357
Samhita Chakraborty United States 8 235 1.1× 177 0.9× 119 1.8× 28 0.4× 26 0.6× 18 330
David Schembri‐Wismayer United States 9 172 0.8× 175 0.9× 64 1.0× 143 2.2× 64 1.5× 12 369
François‐Régis Ferrand France 11 211 1.0× 143 0.7× 34 0.5× 96 1.5× 47 1.1× 35 414
Kimihide Kusafuka Japan 13 205 0.9× 299 1.5× 80 1.2× 209 3.2× 68 1.6× 37 534
Rina Jiromaru Japan 11 196 0.9× 203 1.0× 32 0.5× 57 0.9× 137 3.2× 32 357
Paul Chih‐Hsueh Chen Taiwan 9 140 0.6× 93 0.5× 70 1.0× 91 1.4× 43 1.0× 9 379
Joaquin Garcia United States 6 280 1.3× 231 1.2× 28 0.4× 126 1.9× 70 1.6× 9 450
Wim van Boxtel Netherlands 9 306 1.4× 313 1.6× 79 1.2× 67 1.0× 44 1.0× 18 431
Holger Nagel Germany 10 163 0.7× 174 0.9× 42 0.6× 81 1.2× 14 0.3× 18 371

Countries citing papers authored by Aditya Shreenivas

Since Specialization
Citations

This map shows the geographic impact of Aditya Shreenivas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aditya Shreenivas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aditya Shreenivas more than expected).

Fields of papers citing papers by Aditya Shreenivas

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Aditya Shreenivas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aditya Shreenivas. The network helps show where Aditya Shreenivas may publish in the future.

Co-authorship network of co-authors of Aditya Shreenivas

This figure shows the co-authorship network connecting the top 25 collaborators of Aditya Shreenivas. A scholar is included among the top collaborators of Aditya Shreenivas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Aditya Shreenivas. Aditya Shreenivas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
Kato, Shumei, Mina Nikanjam, Aditya Shreenivas, et al.. (2024). On the right TRACK: Providing comprehensive genomic profiling (CGP) and molecular tumor board (MTB) for patients (pts) with rare cancers.. Journal of Clinical Oncology. 42(16_suppl). 3127–3127. 2 indexed citations
4.
5.
Zenga, Joseph, Musaddiq Awan, Jamie Foeckler, et al.. (2024). Tumor-specific T cells in head and neck cancer have rescuable functionality and can be identified through single-cell co-culture. Translational Oncology. 42. 101899–101899. 2 indexed citations
6.
Thapa, Bicky, Aditya Shreenivas, Kathryn Bylow, et al.. (2024). Successful Targeting of Somatic VHL Alterations With Belzutifan in Two Cases. SHILAP Revista de lepidopterología. 7(4). 308–313. 1 indexed citations
7.
Zenga, Joseph, Musaddiq Awan, Becky Massey, et al.. (2024). Type I interferon signaling promotes radioresistance in head and neck cancer. Translational Cancer Research. 13(5). 2535–2543. 5 indexed citations
8.
Chakrabarti, Sakti, Emily Steinhagen, Ahmed A. Mohamed, et al.. (2023). P-219 Non-operative management of localized mismatch repair deficient colon cancer: A real-world perspective. Annals of Oncology. 34. S93–S93. 1 indexed citations
9.
Tahir, Stephen K., Emiliano Calvo, Benedito A. Carneiro, et al.. (2023). Activity of eftozanermin alfa plus venetoclax in preclinical models and patients with acute myeloid leukemia. Blood. 141(17). 2114–2126. 9 indexed citations
10.
Shreenivas, Aditya, Filip Jankú, Mohamed A. Gouda, et al.. (2023). ALK fusions in the pan-cancer setting: another tumor-agnostic target?. npj Precision Oncology. 7(1). 101–101. 44 indexed citations
11.
Thapa, Bicky, Anikó Szabó, Gulrayz Ahmed, et al.. (2023). ATM or CHEK2 alterations: Potential biomarkers of improved outcomes with irinotecan-containing chemotherapy in advanced pancreatic ductal adenocarcinoma.. Journal of Clinical Oncology. 41(4_suppl). 754–754. 1 indexed citations
12.
Banerjee, Anjishnu, Aditya Shreenivas, Monica Shukla, et al.. (2023). Definitive Chemoradiation Associated with Improved Survival Outcomes in Patients with Synchronous Oligometastatic Esophageal Cancer. Cancers. 15(9). 2523–2523. 3 indexed citations
13.
Limaye, Sewanti, et al.. (2022). Sustained response on sequential anti-FGFR therapy in metastatic gall bladder cancer: a case report and literature review. Journal of Cancer Research and Clinical Oncology. 149(8). 4915–4923. 2 indexed citations
14.
Zenga, Joseph, et al.. (2022). Chronic stress promotes an immunologic inflammatory state and head and neck cancer growth in a humanized murine model. Head & Neck. 44(6). 1324–1334. 5 indexed citations
15.
McCormick, Caroline A., Michael Stadler, Becky Massey, et al.. (2021). A closer look at 30 day hospital readmissions after head and neck cancer surgery. American Journal of Otolaryngology. 42(5). 103146–103146. 2 indexed citations
16.
Kamgar, Mandana, Sakti Chakrabarti, Aditya Shreenivas, & Ben George. (2021). Evolution of Systemic Therapy in Metastatic Pancreatic Ductal Adenocarcinoma. Surgical Oncology Clinics of North America. 30(4). 673–691. 2 indexed citations
17.
Divi, Vasu, Becky Massey, Bruce H. Campbell, et al.. (2019). Lymph node yield, depth of invasion, and survival in node-negative oral cavity cancer. Oral Oncology. 98. 125–131. 27 indexed citations
18.
Stadler, Michael, Becky Massey, Bruce H. Campbell, et al.. (2019). Intermediate-grade carcinoma of the parotid and the impact of adjuvant radiation. American Journal of Otolaryngology. 40(6). 102282–102282. 10 indexed citations
19.
Coltoff, Alexander, et al.. (2018). A single-institution experience of performing bloodless transplant in Jehovah’s Witness patients. Hematology/Oncology and Stem Cell Therapy. 12(1). 44–49. 7 indexed citations
20.
Shreenivas, Aditya, et al.. (2012). A rare case of factor V inhibitor in a patient on amiodarone therapy. Blood Coagulation & Fibrinolysis. 23(4). 342–344. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Dan Ma Breakdown of academic impact, for papers by Samhita Chakraborty Breakdown of academic impact, for papers by David Schembri‐Wismayer Breakdown of academic impact, for papers by François‐Régis Ferrand Breakdown of academic impact, for papers by Kimihide Kusafuka Breakdown of academic impact, for papers by Rina Jiromaru Breakdown of academic impact, for papers by Paul Chih‐Hsueh Chen Breakdown of academic impact, for papers by Joaquin Garcia Breakdown of academic impact, for papers by Wim van Boxtel Breakdown of academic impact, for papers by Holger Nagel
Rankless by CCL
2026